Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults. Issue 7 (6th February 2020)

• Record Type: Journal Article
• Authors: Roux, Alexandre; Tauziede-Espariat, Arnault; Zanello, Marc; Peeters, Sophie; Zah-Bi, Gilles; Parraga, Eduardo; Edjlali, Myriam; Lechapt, Emmanuèle; Shor, Natalia; Bellu, Luisa; Berzero, Giulia; Dormont, Didier; Dezamis, Edouard; Chretien, Fabrice; Oppenheim, Catherine; Sanson, Marc; Varlet, Pascale; Capelle, Laurent; Dhermain, Frédéric; Pallud, Johan
• Is Part Of: Neuro-oncology. Volume 22:Issue 7(2020)
• Page Start: 993
• Page End: 1005
• Publication Date: 2020-02-06
• Subjects: oligodendroglioma -- IDH-mutant -- 1p/19q codeletion -- imaging growth rate -- velocity index; Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noaa022
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: Background: We quantified the spontaneous imaging growth rate of oligodendrogliomas. We assessed whether (i) it discriminates between World Health Organization (WHO) grade II and grade III oligodendrogliomas, and (ii) grade III oligodendrogliomas with neo-angiogenesis are associated with more fast growth rates (≥8 mm/y). Methods: This work employed a retrospective bicentric cohort study (2010–2016) of adult patients harboring a newly diagnosed supratentorial oligodendroglioma, isocitrate dehydrogenase ( IDH ) mutant and 1p/19q codeleted (WHO 2016 classification), with a minimum of 2 available MRIs before any treatment (minimum 6-week interval) to measure the spontaneous tumor growth rate. Results: We included 108 patients (age 44.7 ± 14.1 y, 60 males). The tumor growth rate was higher in grade III oligodendrogliomas with neo-angiogenesis ( n = 37, median 10.4 mm/y, mean 10.0 ± 6.9) than in grade III oligodendrogliomas with increased mitosis count only (cutoff ≥6 mitoses, n = 18, median 3.9 mm/y, mean 4.5 ± 3.2; P = 0.004), and higher than in grade II oligodendrogliomas ( n = 53, median 2.3 mm/y, mean 2.8 ± 2.2; P < 0.001). There was increased prevalence of fast tumor growth rates in grade III oligodendrogliomas with neo-angiogenesis (54.1%) compared with grade III oligodendrogliomas with increased mitosis count only (11.1%; P < 0.001), and in grade II oligodendrogliomas (0.0%; P < 0.001). The tumor growth rate trends did not differ between centers ( P = 0.121). Neo-angiogenesis ( P < 0.001) and mitosis count at ≥9 ( P = 0.013) were independently associated with tumor growth rates ≥8 mm/year. A tumor growth rate ≥8 mm/year was the only predictor independently associated with shorter progression-free survival ( P = 0.041). Conclusions: The spontaneous tumor growth rate recapitulates oligodendroglioma aggressiveness, permits identification of grade III oligodendrogliomas preoperatively when ≥8 mm/year, and questions the grading by mitosis count.